Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromhexine for prevention of postoperative cholangitis after hepatobiliary resection for biliary cancer
jRCTs041240207Recruiting
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of bromhexine in cholangiolitis and biliary cancer. Primary endpoint: Incidence of postoperative cholangitis among evaluable enrolled patients. Started Mar 2025; status: recruiting.
02
Drugs
bromhexine
03
Conditions
cholangiolitisbiliary cancer
Beyond the preview
Go deeper on jRCTs041240207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041240207.